Introduction: The purpose of this study was to compare the cell viability of dental pulp cells treated with Biodentine (Septodont, Saint-Maur, France) and mineral trioxide aggregate (MTA) and the in vitro and in vivo expression of mineralization markers induced by the 2 materials. Methods: Human dental pulp cells isolated from 6 permanent teeth were stimulated with Biodentine and MTA extracts. Cell viability was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, and quantitative reverse-transcriptase polymerase chain reaction was used to determine the expression of mineralization markers. Specimens of teeth from dogs treated with Biodentine and MTA after pulpotomy were used to determine the presence of osteopontin and alkaline phosphatase by immunohistochemistry and runtrelated transcription factor 2 by immunofluorescence. Results: No significant differences in cell viability were found between MTA and Biodentine extracts and controls after 24 and 48 hours (P > .05). After 48 hours, osteopontin (SPP1), alkaline phosphatase (ALP), and runt-related transcription factor 2 (RUNX2) expression was higher in MTA and Biodentine than in controls (P < .05). Osteopontin staining was more intense and spread over a greater number of areas in Biodentine than in MTA samples (P < .0001). Alkaline phosphatase staining of a mineralized tissue bridge was significantly different between materials (P < .0001), but no difference in alkaline phosphatase staining of pulp tissue was found between MTA and Biodentine (P = .2). Also, no significant difference in the number of cells labeled for runt-related transcription factor 2 by immunofluorescence was observed between materials (P > .05). Conclusions: Biodentine stimulated similar markers as MTA, but staining was more intense and spread over a larger area of the pulp tissue. (J Endod 2016;-:1-8) 
M
ineral trioxide aggregate (MTA) (ProRoot MTA; Dentsply Tulsa Dental, Johnson City, TN) has been extensively used in endodontics to protect pulp tissue after pulpotomy for carious and traumatic exposures. Biodentine (Septodont, Saint-Maur, France) is a novel root-end filling material, which is a powder consisting mainly of tricalcium silicate (Ca 3 SiO 5 ), zirconium oxide, and calcium carbonate and the mixing liquid is composed of water, calcium chloride, and a hydrosoluble polymer (1) . Similar to MTA, Biodentine has been shown to release calcium hydroxide (2) , induce reparative dentin synthesis (3) , and have antibacterial activity (4) . Biodentine offers an additional advantage over MTA in that it can be used as a temporary enamel substitute and permanent dentin substitute (5) . Because this new material comes in contact with both pulp and periapical tissues, biocompatibility is crucial (6) .
Biodentine has shown tissue compatibility and exhibited tissue bridge formation similar to that of MTA (7) . Human clinical cases using Biodentine for conservative and radical endodontic treatments showed satisfactory results regarding the induction of mineralization (8) (9) (10) . However, the differentiation of pulp cells into odontoblastlike cells (11) and the mineralization (3, 12) induced by this material are not fully known.
Osteopontin (gene name SPP1), alkaline phosphatase (gene name ALPL), bone sialoprotein (gene name IBSP), dentin sialophosphoprotein (gene name DSPP), and dentin matrix protein 1 (gene name DMP1) have been used as markers of differentiation in osteoblasts and odontoblasts to investigate the mechanisms of mineralization (13) (14) (15) (16) . Alkaline phosphatase is found in the early stages of osteoblast and odontoblast differentiation and provides inorganic phosphate to form hydroxyapatite (ie, the first step of mineralization) (17) . Osteopontin is an extracellular matrix acidic glycoprotein that has been implicated in many physiological and pathological events, including the maintenance or reconfiguration of tissue integrity during inflammatory processes (18) . The runt-related transcription factor 2 (gene name RUNX2) has been linked to bone and dental mineralization and plays a primary role in the differentiation of osteoblasts and homeostasis of mineralized tissues (19, 20) .
However, further in vivo studies with Biodentine are needed to elucidate the mechanism of action for biostimulation because differences have been reported between Biodentine and MTA. Thus, this study aimed to compare the cell viability of dental pulp cells treated with Biodentine and MTA and the expression of mineralization markers in vitro and in vivo induced by both materials.
Materials and Methods

Explant Cell Culture
Teeth extracted for orthodontic reasons were obtained after informed patient consent (n = 6) and under institutional review board approval (process # 25315013.0.0000.5419). Human dental pulp cells were isolated from collected teeth and grown in medium consisting of Dulbecco's Modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 1% penicillin/streptomycin, and amphotericin. Cells from the third through fifth passages were used for experimentation.
Preparation of Materials
This study is in accordance with ISO 10993-5:2009 (21). The extraction method was used to put the materials (Table 1) in contact with the cells tested. Two cylindric matrices 10 mm in diameter and 5 mm in height were prepared from metallic matrix bands. The materials were mixed according to the manufacturer's instructions on a sterile glass slab in a laminar flow cabinet and introduced into the sterile matrices using sterile instruments for a volume of 47.5 mm 3 . The material prepared was kept in the laminar flow cabinet under ultraviolet light for 1 hour from the initial setting and then placed separately in polypropylene tubes with 5 mL incomplete DMEM medium and stored refrigerated for 72 hours before the experiment. The remaining material was discarded; the extracts were filtered, and 1:10 and 1:100 serial dilutions were prepared from the initial extracts (1:1). The 1:1, 1:10, and 1:100 solutions were stored refrigerated until use.
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium Bromide Assay: Cell Viability 1 Â 10 5 cells/well were plated in a 96-well plate, preincubated for 12 hours in serum-free media, and then treated with different MTA and Biodentine extracts for 24 and 48 hours. A tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (0.5 mg/mL, Sigma M-5655 MTT Colorimetric Assay; Sigma-Aldrich, St Louis, MO) was added to each well and incubated at 37 C for 3 hours in the dark. The absorbance in each well was determined at 570 nm using a microplate reader (mQuanti; Bio-tek Instruments, Inc, Winooski, VT). Cell viability in each group was expressed as a percentage and compared with the control group (culture medium). Data were analyzed using 1-way analysis of variance followed by the Bonferroni post test (a = 0.05).
Quantitative Reverse-transcriptase Polymerase Chain Reaction: Expression of Mineralization-related Genes SPP1, IBSP, DSPP, ALPL, DMP1, and RUNX2 messenger RNA levels were assayed by quantitative reverse-transcriptase chain reaction using fluorescent markers. After stimulation with MTA and Biodentine extracts, cells were harvested for the extraction of total RNA by the column method using thiocyanate guanidine (RNEasy; Qiagen Inc, Valencia, CA) according to the manufacturer's instructions. Total RNA was estimated using 2 mL of each sample with a Nanodrop spectrophotometer (Thermo Scientific, Wilmington, DE).
Next, reverse transcription was performed for complementary DNA synthesis followed by polymerase chain reaction. Primers and probes for SPP1 (Hs00959010_m1), IBSP (Hs00173720_m1), DSPP (Hs00171962_m1), ALPL (Hs01029144_m1), RUNX2 (Hs00231692_m1), and DMP1 (Hs01009391_g1) were obtained commercially and are proprietary; thus, sequences are not available (TaqMan Gene Expression Assay; Applied Biosystems, Foster City, CA). Glyceraldehyde-3-phosphate dehydrogenase (Hs 02758991_g1) and beta-actin (Hs 01060665_g1) were used as reference genes. Quantitative reverse-transcriptase polymerase chain reactions were performed in duplicate using a StepOne Plus real-time PCR system (Applied Biosystems).
Amplification was performed under the following conditions: activation of AmpliTaq Gold Enzyme (Applied Biosystems) at 95 C for 2 minutes followed by 40 cycles at 95 C for 1 second for DNA denaturation and 60 C for 20 seconds for primer annealing and polymerization. The results were analyzed based on cycle threshold values. Distilled deionized water was used as a negative control of each primer probe pair. Relative expression was calculated based on the equation 2
ÀDDCt
. Relative messenger RNA expression was compared among the groups using 1-way analysis of variance followed by the Tukey test (a = 0.05).
Acquisition of Slides after In Vivo Pulpotomy
The slides used in this section were obtained from the specimen database at the Children's Clinic Department, School of Dentistry of Ribeirão Preto, University of São Paulo, Brazil, in accordance with ISO 7405:2008 (22) . This study was approved by the Institutional Animal Research Ethics Committee (process #2013.1.643.58.5).
In total, 87 specimens of the upper second and third premolars and the lower second, third, and fourth premolars from four 12-month-old male and female Beagle dogs treated with MTA (n = 35) and Biodentine (n = 52) were evaluated 120 days after pulpotomy.
Immunohistochemistry: In Vivo Osteopontin and Alkaline Phosphatase Staining
To determine the expression of mineralization-related markers, immunohistochemistry assays for osteopontin and alkaline phosphatase were conducted in the Biodentine (n = 46) and MTA (n = 29) groups.
The slides were deparaffinized, hydrated in a decreasing ethanol series, and kept in phosphate-buffered saline (PBS). Next, tissue sections were microwaved (7 Â 12 seconds at 2-minute intervals) with sodium citrate buffer (pH = 6.0) for antigen retrieval. After temperature stabilization, the slides were washed with PBS (3Â) for 5 minutes, and endogenous peroxidase activity was blocked with 3% hydrogen peroxide for 40 minutes. Slides were further washed with PBS (3Â) for 5 minutes, and nonspecific binding sites were blocked with 5% bovine serum albumin (Sigma-Aldrich) for 60 minutes. The tissues were then incubated with primary antibodies for osteopontin (ab8448, rabbit polyclonal; Abcam, Cambridge, MA) and alkaline phosphatase (ab54778, mouse monoclonal, Abcam) at 4 C overnight. Next, slides were washed and incubated with antimouse or antirabbit biotinylated secondary antibodies for 1 hour, washed in PBS, and incubated with streptavidin conjugated with horseradish peroxidase for 20 minutes; 3,3 0 -diaminobenzidine (Sigma-Aldrich) was used as the enzyme substrate for 5 minutes. The slides were washed with PBS, counterstained with Harris's hematoxylin for 15 seconds, washed with distilled water, dehydrated in increasing ethanol concentrations, and mounted in Entellan (Merck, Darmstadt, Germany). Control slides in which the primary antibody was omitted were used to test the specificity of immunostaining.
Osteopontin and alkaline phosphatase staining in the mineralized tissue bridge and pulp tissue was scored (1: mild, 2: moderate, and 3: intense) at the apical, middle, and cervical root canal thirds. For this analysis, all slides were prepared in the same batch to obtain a standardized staining and were evaluated by an experienced blind examiner. The data were converted into percentage, and groups were compared using the chi-square test (a = 0.05).
Indirect Immunofluorescence: Runt-related Transcription Factor 2 Labeling
To determine the expression of runt-related transcription factor 2 and its role in the synthesis of mineralization proteins and as an indicator of cell differentiation, indirect immunofluorescence assays were conducted in the Biodentine (n = 6) and MTA (n = 6) groups.
The slides were prepared as described previously. Next, the slides were washed with PBS (3Â) for 5 minutes and 1 mg/mL sodium borohydride solution (3Â) (Dinâmica Qu ımica Contemporânea Ltda, Diadema, SP, Brazil) for 15 minutes. Nonspecific binding sites were blocked with 5% bovine serum albumin (Sigma-Aldrich) for 60 minutes. Immunolabeling was performed using primary antibody for runt-related transcription factor 2 (ab23981, rabbit polyclonal, Abcam) at 4 C overnight. The following day, the slides were washed in PBS (3Â) and incubated with secondary antibody (antirabbit immunoglobulin G conjugated with fluorescein) for 1 hour in a dark chamber. The slides were further washed with PBS (3Â), and the nuclei were stained with 4 0 ,6-diamidino-2-phenylindole (0.5 mg/mL) (Santa Cruz Biotechnology Inc, Dallas, TX) for 5 minutes. Slides were mounted with ProLong Gold Antifade (Molecular Probes Inc, Eugene, OR). The percentage of positively stained cells was determined in the layer adjacent to the newly formed mineralized tissue, the intact odontoblastic layer of pulp tissue, and cells within the central region of this tissue. First, the regions were photographed by fluorescence microscopy at 20Â magnification using Alexa Fluor (Carl Zeiss, G€ ottingen, Germany) and 4 0 ,6-diamidino-2-phenylindole filters. Next, the images were analyzed using ImageJ software (National Institutes of Health, Bethesda, MD) to determine the number of positively stained cells by selecting the ''analyze particles'' tool; pixel size was set as the average size of previously measured cell nuclei. The total cell count Basic Research-Biology and stained cell count were expressed as a percentage, and staining was compared across groups using the Tukey test (a = 0.05).
Results
In Vitro
Cell viability was significantly lower in 1:1 and 1:10 MTA and Biodentine extracts than in controls at 24 and 48 hours (P < .05, Fig. 1A  and B) . Conversely, cell viability was not affected by 1:100 dilutions, and no significant differences were found between 1:100 MTA and Biodentine extracts and controls after 24 and 48 hours (P > .05, Fig. 1A and B). Because cell viability was not affected by 1:100 dilutions, this concentration was used for the following experiment.
After 24 hours of stimulation, MTA and Biodentine did not modulate SPP1, ALPL, and RUNX2 compared to controls (P > .05, Fig. 1C , E, and G). Conversely, MTA and Biodentine induced higher SPP1, ALPL, and RUNX2 gene expression than controls at 48 hours (P < .05, Fig. 1D, F, and H) . No IBSP, DSPP, and DMP1 expression was detected in either experimental period.
Mineralization and In Vivo Osteopontin and Alkaline Phosphatase Staining
Biodentine and MTA induced mineralized tissue formation within the cervical third of the dental root canal pulp ( Fig. 2A-D) . We investigated mineralizing proteins that could be involved in this process.
Osteopontin staining of the mineralized tissue bridge and adjacent areas was significantly different between the Biodentine and MTA groups (P < .0001). Mild staining was observed in 29% of MTA cases, whereas mild, moderate, and intense staining was observed in 26%, 43%, and 22% of Biodentine cases, respectively (Fig. 3) .
Alkaline phosphatase staining of the mineralized tissue bridge was significantly different between filling materials (P < .0001). Mild staining was found in 14% of MTA cases and 48% of Biodentine cases (Fig. 4) . Osteopontin and alkaline phosphatase staining was also evaluated in pulp tissue at the apical, middle, and cervical root canal thirds. Osteopontin staining was significantly different between MTA and Biodentine (P < .0001) and was concentrated at the cervical third in the 2 groups. For MTA, no staining was observed in 57% of cases and 29% of cases were labeled at the cervical and middle thirds, but no staining was observed at the apical third. No staining was observed in 39% of Biodentine cases, 52% of cases were stained at the cervical third, and 26% at the middle and apical thirds (Fig. 3A-F) .
No significant difference in alkaline phosphatase staining of pulp tissue was found between MTA and Biodentine (P = .2). High staining intensity was observed at all root canal thirds in the 2 groups; 100% of MTA cases were stained at the cervical and middle thirds and 86% at the apical third, whereas 96% of Biodentine cases were stained at the cervical third and 91% at the middle and apical thirds (Fig. 4A-F) .
In Vivo Runt-related Transcription Factor 2 Immunofluorescence
No significant difference was found between Biodentine and MTA in the number of positively labeled cells by fluorescence in the central portion of the pulp tissue (Biodentine: 67.3%, MTA: 61.7%; P > .05, Fig. 5E-H ) and the intact odontoblastic layer (Biodentine: 68.7%, MTA: 67%; P > .05, Fig. 5I-L) . Similarly, no significant difference was found in the number of positively stained cells in the region adjacent to newly formed mineralized tissue between Biodentine (87%) and MTA (58%) (P > .05, Fig. 5A-D) .
Discussion
Studies comparing the cell viability of Biodentine and MTA have shown the similarity between the 2 materials (23) (24) (25) (26) (27) . Those results are in agreement with the findings of this study, which showed that Biodentine and MTA had a similar effect on cell viability. In addition to maintaining cell viability, capping materials must be able to induce the formation of mineralized tissue bridges when in contact with pulp tissue in procedures such as pulpotomies and pulp capping treatments. SPP1 and RUNX2 were stimulated in this study in agreement with a previous study (14) , indicating that these genes may play an early role in the mineralization process and their longterm maintenance. Alkaline phosphatase activity is required for mineral deposition in dentinal collagen sheets (28) . In this study, staining was diffuse and extracellular, which is in agreement with other studies that suggested that alkaline phosphatase plays a role in the organism's reaction to injury. Increased ALPL gene expression in vitro has also been observed in other studies after MTA and Biodentine stimulation (29) (30) (31) . Conversely, decreased alkaline phosphatase expression with simultaneous reduction in enzyme activity has been shown after Basic Research-Biology 11 days of culture, which may be indicative of osteoblast maturation, thus supporting the involvement of this marker in initial mineralization (11) .
Increased SPP1 gene expression was also shown in vitro after Biodentine and MTA stimulation in a previous study with no difference between materials (14) , which is in line with the current findings. The presence of osteopontin was also investigated by immunohistochemistry in a pulp capping study with calcium hydroxide, MTA, and Biodentine in a rat pulp injury model. The dentin bridge was strongly positive for osteopontin in all samples, whereas adjacent cells showed weak staining in the calcium hydroxide group and more intense staining in the MTA and Biodentine groups (32) . Similar results were observed in this study, but osteopontin staining was more intense and spread over a greater number of areas in Biodentine samples. To date, no study had shown such broad osteopontin expression extending to the apical pulp.
The RUNX2 gene coordinates multiple signaling pathways related to osteoblastic differentiation (33) , odontoblastic differentiation (34) , and tooth development (35) . Increased RUNX2 gene expression in vitro was detected in this study and similar findings have been reported previously (14) . After longer experimental periods the same pattern of RUNX2 expression induced by both capping materials has also been shown elsewhere (23) . Our study detected runt-related transcription factor 2 expression in vivo by immunofluorescence but found no significant difference in expression levels between Biodentine and MTA.
This study showed no significant differences in cell viability between MTA and Biodentine extracts, and both similarly induce SPP1, ALPL, and RUNX2 gene expression. In vivo, Biodentine stimulated similar mineralization markers as MTA, but staining was more intense in root dental pulp and dentin bridges. Our findings suggest that Biodentine could be advantageous in the long-term for conservative endodontic treatment to offset the high cost of the material. However, further studies are needed to determine the exact role of each mineralization protein and the signaling pathways that are activated to initiate mineralized tissue formation.
